Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
{{output}}
Background: Monoclonal antibodies (mABs) targeting the calcitonin gene-related peptide (CGRP) pathway represent the first disease-specific preventive migraine therapy. Growing evidence suggests that they are effective in the prev... ...
